Helal A, Abdelrazik A, Hogrefe K. Safety of Everolimus and Sirolimus-Eluting Coronary Devices in a Patient With Porphyria Presenting With Acute Coronary Syndromes: A Two-Year Follow-Up. Catheter Cardiovasc Interv 2025;106:2901-2905.
PMID: 40898588